deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01922115

The Effect of Anticholinergics on Cognitive Function in the Elderly (ACE)

The Effect of Anticholinergics on Cognitive Function in the Elderly: a Randomized Controlled Trial

Sponsor: American Urogynecologic Society

Conditions Cognitive Function Mental Competency Urinary Bladder, Overactive
Interventions Placebo Trospium Chloride
Updated 9 times since 2017 Last updated: Feb 17, 2017 Started: Jun 30, 2013 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cognitive Function and Mental Competency and is currently completed. American Urogynecologic Society leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~May 2017 · 3 months · monthly snapshotCompleted~May 2017 – ~Jun 2018 · 13 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. May 2017 — Jun 2018 [monthly]

    Completed PHASE4

  3. Feb 2017 — May 2017 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American Urogynecologic Society
  • University of North Carolina, Chapel Hill
Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations